{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:35Z","timestamp":1786988075893,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273781"],"award-info":[{"award-number":["82273781"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1\\u2013070"],"award-info":[{"award-number":["2021-I2M-1\\u2013070"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejmech.2025.117712","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T11:13:15Z","timestamp":1746443595000},"page":"117712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design, synthesis and activity evaluation of benzene sulfonamide derivatives as novel androgen receptor antagonist"],"prefix":"10.1016","volume":"294","author":[{"given":"Cong","family":"Bian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laixing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117712_bib1","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/med.21558","article-title":"A magic drug target: androgen receptor","volume":"39","author":"Li","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117712_bib2","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1038\/onc.2013.274","article-title":"Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver","volume":"33","author":"Chang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2025.117712_bib3","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1245\/s10434-017-5961-9","article-title":"The androgen receptor: is it a promising target?","volume":"24","author":"Gucalp","year":"2017","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ejmech.2025.117712_bib4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ncponc0765","article-title":"Drug insight: role of the androgen receptor in the development and progression of prostate cancer","volume":"4","author":"Taplin","year":"2007","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.ejmech.2025.117712_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.mce.2017.06.013","article-title":"Development of selective androgen receptor modulators (SARMs)","volume":"465","author":"Narayanan","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejmech.2025.117712_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2019.01.054","article-title":"Discovery of deshydroxy bicalutamide derivatives as androgen receptor antagonists","volume":"167","author":"Kandil","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117712_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2013.07.003","article-title":"Androgen receptors in hormone-dependent and castration-resistant prostate cancer","volume":"140","author":"Shafi","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.117712_bib8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/adt.2019.940","article-title":"Assays to interrogate the ability of compounds to inhibit the AF-2 or AF-1 transactivation domains of the androgen receptor","volume":"17","author":"Fancher","year":"2019","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ejmech.2025.117712_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1573409915666190502153307","article-title":"New insights into the binding mechanism of Co-regulator BUD31 to AR AF2 site: structural determination and analysis of the mutation effect","volume":"16","author":"Song","year":"2020","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.ejmech.2025.117712_bib10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/er.2002-0032","article-title":"Androgen receptor in prostate cancer","volume":"25","author":"Heinlein","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejmech.2025.117712_bib11","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s11255-018-1964-0","article-title":"Androgen receptor: what we know and what we expect in castration-resistant prostate cancer","volume":"50","author":"Cai","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.ejmech.2025.117712_bib12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3389\/fonc.2019.00858","article-title":"Androgen receptor signaling in the development of castration-resistant prostate cancer","volume":"9","author":"Feng","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.117712_bib13","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.3390\/cells9122653","article-title":"Androgen receptor signaling pathway in prostate cancer: from genetics to clinical applications","volume":"9","author":"Aurilio","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117712_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejmech.2019.03.041","article-title":"Discovery and biological evaluation of novel androgen receptor antagonist for castration-resistant prostate cancer","volume":"171","author":"Yu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117712_bib15","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1158\/2159-8290.CD-20-0751","article-title":"Targeting the p300\/CBP axis in lethal prostate cancer","volume":"11","author":"Welti","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2025.117712_bib16","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1158\/2159-8290.CD-13-0226","article-title":"A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509","volume":"3","author":"Joseph","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2025.117712_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4155\/ppa.15.20","article-title":"Recent advances in allosteric androgen receptor inhibitors for the potential treatment of castration-resistant prostate cancer","volume":"4","author":"Martinez-Ariza","year":"2015","journal-title":"Pharm. Pat. Anal."},{"key":"10.1016\/j.ejmech.2025.117712_bib18","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.1074\/jbc.M407046200","article-title":"The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor","volume":"280","author":"Estebanez-Perpina","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117712_bib19","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.1073\/pnas.0708036104","article-title":"A surface on the androgen receptor that allosterically regulates coactivator binding","volume":"104","author":"Estebanez-Perpina","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2025.117712_bib20","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1021\/jm200532b","article-title":"Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening","volume":"54","author":"Axerio-Cilies","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117712_bib21","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1021\/jm201438f","article-title":"\"true\" antiandrogens-selective non-ligand-binding pocket disruptors of androgen receptor-coactivator interactions: novel tools for prostate cancer","volume":"55","author":"Caboni","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117712_bib22","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/ncomms2912","article-title":"Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer","volume":"4","author":"Ravindranathan","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117712_bib23","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1021\/acs.jmedchem.1c01938","article-title":"Discovery of N-(4-(Benzyloxy)-phenyl)-sulfonamide derivatives as novel antagonists of the human androgen receptor targeting the activation function 2","volume":"65","author":"Chai","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117712_bib24","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3389\/fphar.2018.01419","article-title":"Structural based screening of antiandrogen targeting activation Function-2 binding site","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117712_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fchem.2018.00098","article-title":"Design, synthesis, and evaluation of Dihydrobenzo[cd]indole-6-sulfonamide as TNF-Alpha inhibitors","volume":"6","author":"Deng","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.117712_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202301105","article-title":"Low\u2010temperature n\u2010alkylation of amines with alcohols in protic solvents catalyzed by iridium complexes bearing n\u2010heterocyclic carbenes","volume":"27","author":"Furukawa","year":"2024","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117712_bib27","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/chem.201704788","article-title":"Photoredox\u2010switchable Resorcin[4]arene cavitands: radical control of molecular gripping machinery via hydrogen bonding","volume":"24","author":"Mili\u0107","year":"2018","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.117712_bib28","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1021\/acs.joc.0c01523","article-title":"Transition-metal-free and visible-light-mediated desulfonylation andDehalogenation reactions: hantzsch ester anion as electron and hydrogen AtomDonor","volume":"85","author":"Heredia","year":"2020","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117712_bib29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4062\/biomolther.2019.074","article-title":"A new histone deacetylase inhibitor, MHY4381, induces apoptosis via generation of reactive oxygen species in human prostate cancer cells","volume":"28","author":"Richa","year":"2020","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.ejmech.2025.117712_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejmech.2019.01.036","article-title":"Rational drug design for androgen receptor and glucocorticoids receptor dual antagonist","volume":"166","author":"Wu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117712_bib31","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40262-015-0271-5","article-title":"Clinical pharmacokinetic studies of enzalutamide","volume":"54","author":"Gibbons","year":"2015","journal-title":"Clin. Pharmacokinet."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:11:43Z","timestamp":1765602703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425004775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":31,"alternative-id":["S0223523425004775"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117712","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and activity evaluation of benzene sulfonamide derivatives as novel androgen receptor antagonist","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117712"}}